Clinical Trial Update: Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM) [NA]

View source ↗

Summary

A completed clinical trial investigating postprandial fatty acids and FABP2 in individuals with Type 2 Diabetes Mellitus (with dyslipidemia). The snippet does n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Dyslipidemia, Type 2 Diabetes Mellitus | NA | Status: COMPLETED